ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.43
0.77%
US Tech 100
18,541.20
0.00%
S&P 500
5,354.03
1.18%
US Dollar vs CAD
1.36792
-0.08%
Bitcoin
70,978.41
-0.14%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

  7. RegeneRX Biopharmaceuticals Inc (CE) (RGRX) News

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:RGRX
DateTimeSourceHeadlineSymbolCompany
08/14/20233:01PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/07/20232:57PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/11/20234:13PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/10/20234:19PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/06/20233:35PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/06/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/26/20235:01AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/21/20235:03AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/15/20233:25PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/11/20233:32PMEdgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/14/20223:09PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/12/20223:16PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/19/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/19/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/19/20224:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/19/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/19/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
05/16/20224:11PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/15/20213:35PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/15/20211:56PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/18/20215:05AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/08/20212:52PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/17/20219:32AMEdgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/06/20213:09PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/04/20213:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/04/20213:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/04/20213:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/04/20213:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/22/20214:01PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/19/20213:16PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:RGRX

Your Recent History

GATE
LAIUSDT
LAI [CryptoGPT Token]
BIT
P1Y110
NLBNPIT1Y110 20991231 14...
BIT
P20YO2
NLBNPIT20YO2 20240621 460
TG
AMI
Medondo
LQID
TRXBTC
TRON
ASX
WPLKOI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved